Highmark Health Expands Access to Freespira's Digital Therapeutic Treatment for Panic Attacks, Panic Disorder and PTSD One of nation's largest health plans makes Freespira available to select Medicare and Medicaid beneficiaries in Pennsylvania, Delaware, and West Virginia News provided by Share this article Share this article WASHINGTON, Feb. 3, 2021 /PRNewswire/ -- Freespira, Inc., maker of the first FDA-cleared digital therapeutic to significantly reduce or eliminate symptoms of panic attacks, panic disorder and post-traumatic stress disorder (PTSD) in only 28 days, today announced that Highmark Inc. is expanding access to Freespira to its membership throughout Pennsylvania, Delaware and West Virginia. The expansion of the partnership, will include the addition of remote coaching on the use of the Freespira device for members not connected to a trained behavioral health professional.